Is STSA or QYLD a better dividend investment in 2026?

STSA currently yields 136.36% with a 5% 5-year dividend growth rate. QYLD yields 12.24% with -2.1% growth. The better choice depends on your goal: STSA offers higher current income.

What is the dividend yield difference between STSA and QYLD?

STSA has a forward dividend yield of 136.36% ($1.50/share annually). QYLD yields 12.24% ($2.04/share annually). The yield gap is 124.12 percentage points.

Home › Compare › STSA vs QYLD

STSA vs QYLD: Dividend Comparison 2026

STSA yields 136.36% · QYLD yields 12.24%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 STSA wins by $15.54M in total portfolio value

INVESTMENT

TIME HORIZON10 years

STSA

● Live price

136.36%

Share price

$1.10

Annual div

$1.50

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$15.56M

Annual income

$6,371,447.45

Full STSA calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

12.24%

Share price

$16.70

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.5K

Annual income

$6,038.84

Full QYLD calculator →

Portfolio growth — STSA vs QYLD

📍 STSA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	STSA	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, STSA + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

STSA pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STSA

Annual income on $10K today (after 15% tax)

$11,590.91/yr

After 10yr DRIP, annual income (after tax)

$5,415,730.33/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,040.82/yr

After 10yr DRIP, annual income (after tax)

$5,133.01/yr

At 15% tax rate, STSA beats the other by $5,410,597.32/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STSA + QYLD for your $10,000?

STSA: 50%QYLD: 50%

100% QYLD50/50100% STSA

Portfolio after 10yr

$7.79M

Annual income

$3,188,743.14/yr

Blended yield

40.91%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on STSA right now

STSA

Analyst Ratings

Buy

Hold

Consensus: Hold

Altman Z

-7.4

Piotroski

2/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STSA buys

QYLD buys

No recent congressional trades found for STSA or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSTSAQYLD

Forward yield	136.36% ✓	12.24%
Annual dividend / share	$1.50	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$15.56M	$26.5K ✓
Annual income after 10y	$6,371,447.45 ✓	$6,038.84
Total dividends collected	$14.30M	$28.5K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: STSA vs QYLD ($10,000, DRIP)

Year	STSA Portfolio	STSA Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$24,336	$13,636.36	$10,384	$1,224.49	+$14.0K → STSA
2	$57,055	$31,014.91	$10,900	$1,388.18	+$46.2K → STSA
3	$129,004	$67,955.30	$11,576	$1,590.76	+$117.4K → STSA
4	$281,633	$143,598.62	$12,447	$1,844.20	+$269.2K → STSA
5	$594,333	$292,985.93	$13,567	$2,164.97	+$580.8K → STSA
6	$1,213,779	$577,842.64	$15,003	$2,576.05	+$1.20M → STSA
7	$2,401,642	$1,102,898.48	$16,853	$3,110.04	+$2.38M → STSA
8	$4,609,241	$2,039,484.49	$19,251	$3,813.85	+$4.59M → STSA
9	$8,590,007	$3,658,118.87	$22,390	$4,756.08	+$8.57M → STSA
10	$15,562,755	$6,371,447.45	$26,548	$6,038.84	+$15.54M → STSA

STSA vs QYLD: Complete Analysis 2026

STSA — Stock

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Full STSA Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this STSA vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STSA vs SCHD STSA vs JEPI STSA vs O STSA vs KO STSA vs MAIN STSA vs XYLD STSA vs JEPQ STSA vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.